Aims and objectives

The ESCMID Vaccine Study Group (EVASG) is at the forefront of vaccine research and education. Gathering experts aiming to promote advancement in the field of vaccination, covering public health to special populations, their mission is to: 

  • Document the impact of vaccines
  • Assess perceptions and attitudes of the public towards vaccination
  • Map needs and develop guidelines to keep up with the emergence of new vaccines

Activities and resources

The ESCMID Vaccine Study Group (EVASG) is pleased to offer five travel grants (500 EUR) for young scientist members of EVASG attending ESCMID Global 2025.

Please note that the travel grant is only available to recipients who attend the conference in person.

Eligibility Criteria: 

 * Young scientist member of ESCMID

  * EVASG member

  * Accepted talk, flash poster, or poster presentation on a vaccine-related topic at ESCMID Global 2025 as the presenting author

  * No other funding received for ESCMID Global 2025

Selection Criteria:

  * Type of presentation (talks and flash posters are prioritized over standard poster presentations)

  * Country of residence (LMIC applicants are prioritized over those from HICs)

  * Length of EVASG membership (longer membership receives higher priority)

Application Process:

To apply, please send an email including the following details to EVASG Science Officer Manuel Krone (<Krone_M(at)ukw.de> ) by February 15, 2025 23:59 Central European Time (CET):

  * Full name

  * Address (including country)

  * Date of birth

  * Date of joining EVASG

  * Acceptance email for your abstract (must be attached)

  * CV (must be attached)

We look forward to receiving your applications!

Best regards,

The EVASG executive commitee

EVASG Newsletter, Autumn 2024

Download


EVASG Newsletter, Summer 2024

Download

Impact of vaccination on the presence and severity of symptoms in hospitalized patients with an infection of the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1). 

Beraud G, Bouetard L, Civljak R, Michon J, Tulek N, Lejeune S, Millot R, Garchet-Beaudron A, Lefebvre M, Veliko P, Festou B, Abgrall S, Lizatovic I K, Baldolli A, Esme H, Blanch S, Froidevaux G, Kapincheva N, Faucher JF, Duvnjak M, Afşar E, Švitek L, Yarimoglu S, Yarimoglu R, Janssen C, Epaulard O, on behalf of EVASG. Clin Microbiol Infect. 2023;29(5):642–650.

Go to publication


Exclusion of older adults and immunocompromised individuals in influenza, pneumococcal and COVID-19 vaccine trials before and after the COVID-19 pandemic. 

Bukan K, Pearce-Slade T, Eiberg M, Tinelli M, Yahav D, Tuells J, Epaulard O, Holler JG, Roed C, Søborg C, Jensen Stæhr JU, Barrella Harboe Z. Aging Clin Exp Res. 2023;35(5):917–923.

Go to publication

Measles in the 21st century: Is eradication possible and how? 

Post-graduate course

Go to courses

Executive Committee

  Zitta Barrella Harboe

Zitta Barrella Harboe

Chair
Copenhagen University Hospital, North Zealand. Respiratory Medicine and Infectious Diseases.
Hillerød, Denmark
  Olivier Epaulard

Olivier Epaulard

Treasurer
Grenoble University Hospital
Grenoble, France
  Petar Velikov

Petar Velikov

Secretary
University of Tsukuba
Tsukuba, Japan
  Manuel Krone

Manuel Krone

Science Officer
University Hospital Wuerzburg
Wuerzburg, Germany
  Justyna Kowalska

Justyna Kowalska

Education Officer
Medical University of Warsaw
Warsaw, Poland

Contact

If you have questions or comments for our study group, we warmly invite you to contact us!

Contact form